T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.
Rasoulouniriana D, Santana-Magal N, Gutwillig A, Farhat-Younis L, Tal L, Amar S, Milyavsky M, Muddineni SSNA, Solomon N, Shpilt H, Dotan S, Pilpel N, Waskow C, Feinmesser M, Rider P, Carmi Y.
Rasoulouniriana D, et al. Among authors: carmi y.
Cancer Immunol Res. 2023 Jun 2;11(6):792-809. doi: 10.1158/2326-6066.CIR-22-0423.
Cancer Immunol Res. 2023.
PMID: 37070661
Free PMC article.